Journal of Gastric Cancer

  • 제13권1호
  • /
  • Pages.3-18
  • /
  • 2013
  • /
  • 2093-582X(pISSN)
  • /
  • 2093-5641(eISSN)
대한위암학회 (The Korean Gastric Cancer Association)
권호 표지
DOI QR코드

DOI QR Code

Surgical Treatment of Gastric Gastrointestinal Stromal Tumor

  • Kong, Seong-Ho (Department of Surgery, Cancer Research Institute, Seoul National University College of Medicine) ;
  • Yang, Han-Kwang (Department of Surgery, Cancer Research Institute, Seoul National University College of Medicine)
  • 투고 : 2013.03.06
  • 심사 : 2013.03.10
  • 발행 : 2013.03.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Gastrointestinal stromal tumor is the most common mesenchymal tumor in the gastrointestinal tract and is most frequently developed in the stomach in the form of submucosal tumor. The incidence of gastric gastrointestinal stromal tumor is estimated to be as high as 25% of the population when all small and asymptomatic tumors are included. Because gastric gastrointestinal stromal tumor is not completely distinguished from other submucosal tumors, a surgical excisional biopsy is recommended for tumors >2 cm. The surgical principles of gastrointestinal stromal tumor are composed of an R0 resection with a normal mucosa margin, no systemic lymph node dissection, and avoidance of perforation, which results in peritoneal seeding even in cases with otherwise low risk profiles. Laparoscopic surgery has been indicated for gastrointestinal stromal tumors <5 cm, and the indication for laparoscopic surgery is expanded to larger tumors if the above mentioned surgical principles can be maintained. A simple exogastric resection and various transgastric resection techniques are used for gastrointestinal stromal tumors in favorable locations (the fundus, body, greater curvature side). For a lesion at the gastroesophageal junction in the posterior wall of the stomach, enucleation techniques have been tried preserve the organ's function. Those methods have a theoretical risk of seeding a ruptured tumor, but this risk has not been evaluated by well-designed clinical trials. While some clinical trials are still on-going, neoadjuvant imatinib is suggested when marginally unresectable or multiorgan resection is anticipated to reduce the extent of surgery and the chance of incomplete resection, rupture or bleeding.

키워드

참고문헌

  1. Mucciarini C, Rossi G, Bertolini F, Valli R, Cirilli C, Rashid I, et al. Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. BMC Cancer 2007;7:230. https://doi.org/10.1186/1471-2407-7-230
  2. Kawanowa K, Sakuma Y, Sakurai S, Hishima T, Iwasaki Y, Saito K, et al. High incidence of microscopic gastrointestinal stromal tumors in the stomach. Hum Pathol 2006;37:1527- 1535. https://doi.org/10.1016/j.humpath.2006.07.002
  3. Agaimy A, Dirnhofer S, Wünsch PH, Terracciano LM, Tornillo L, Bihl MP. Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect. Am J Surg Pathol 2008;32:1553-1559. https://doi.org/10.1097/PAS.0b013e31817587ea
  4. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998;152:1259- 1269.
  5. Cho MY, Sohn JH, Kim JM, Kim KM, Park YS, Kim WH, et al. Current trends in the epidemiological and pathological characteristics of gastrointestinal stromal tumors in Korea, 2003-2004. J Korean Med Sci 2010;25:853-862. https://doi.org/10.3346/jkms.2010.25.6.853
  6. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006;23:70-83. https://doi.org/10.1053/j.semdp.2006.09.001
  7. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51-58. https://doi.org/10.1097/00000658-200001000-00008
  8. The Information Committee of the Korean Gastric Cancer Association. 2005-2006 nationwide gastric submucosal tumor report in Korea. J Korean Gastric Cancer Assoc 2008;8:104-109.
  9. Yang HK, Park do J, Lee HJ, Kim HH, Kim WH, Lee KU. Clinicopathologic characteristics of gastrointestinal stromal tumor of the stomach. Hepatogastroenterology 2008;55:1925- 1930.
  10. Cassier PA, Ducimetiere F, Lurkin A, Ranchere-Vince D, Scoazec JY, Bringuier PP, et al. A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region. Br J Cancer 2010;103:165-170. https://doi.org/10.1038/sj.bjc.6605743
  11. Hwang JH, Saunders MD, Rulyak SJ, Shaw S, Nietsch H, Kimmey MB. A prospective study comparing endoscopy and EUS in the evaluation of GI subepithelial masses. Gastrointest Endosc 2005;62:202-208. https://doi.org/10.1016/S0016-5107(05)01567-1
  12. Sepe PS, Brugge WR. A guide for the diagnosis and management of gastrointestinal stromal cell tumors. Nat Rev Gastroenterol Hepatol 2009;6:363-371. https://doi.org/10.1038/nrgastro.2009.43
  13. Eckardt AJ, Wassef W. Diagnosis of subepithelial tumors in the GI tract. Endoscopy, EUS, and histology: bronze, silver, and gold standard? Gastrointest Endosc 2005;62:209-212. https://doi.org/10.1016/j.gie.2005.05.001
  14. Nowain A, Bhakta H, Pais S, Kanel G, Verma S. Gastrointestinal stromal tumors: clinical profile, pathogenesis, treatment strategies and prognosis. J Gastroenterol Hepatol 2005;20:818-824. https://doi.org/10.1111/j.1440-1746.2005.03720.x
  15. Hunt GC, Smith PP, Faigel DO. Yield of tissue sampling for submucosal lesions evaluated by EUS. Gastrointest Endosc 2003;57:68-72.
  16. Cantor MJ, Davila RE, Faigel DO. Yield of tissue sampling for subepithelial lesions evaluated by EUS: a comparison between forceps biopsies and endoscopic submucosal resection. Gastrointest Endosc 2006;64:29-34. https://doi.org/10.1016/j.gie.2006.02.027
  17. Kataoka M, Kawai T, Yagi K, Sugimoto H, Yamamoto K, Hayama Y, et al. Mucosal cutting biopsy technique for histological diagnosis of suspected gastrointestinal stromal tumors of the stomach. Dig Endosc 2012. [Epub ahead of print]
  18. Karaca C, Turner BG, Cizginer S, Forcione D, Brugge W. Ac curacy of EUS in the evaluation of small gastric subepithelial lesions. Gastrointest Endosc 2010;71:722-727. https://doi.org/10.1016/j.gie.2009.10.019
  19. Palazzo L, Landi B, Cellier C, Cuillerier E, Roseau G, Barbier JP. Endosonographic features predictive of benign and malignant gastrointestinal stromal cell tumours. Gut 2000;46:88-92. https://doi.org/10.1136/gut.46.1.88
  20. Jeon SW, Park YD, Chung YJ, Cho CM, Tak WY, Kweon YO, et al. Gastrointestinal stromal tumors of the stomach: endosonographic differentiation in relation to histological risk. J Gastroenterol Hepatol 2007;22:2069-2075. https://doi.org/10.1111/j.1440-1746.2006.04767.x
  21. Nishida T, Hirota S, Yanagisawa A, Sugino Y, Minami M, Yamamura Y, et al; GIST Guideline Subcommittee. Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version. Int J Clin Oncol 2008;13:416-430. https://doi.org/10.1007/s10147-008-0798-7
  22. Blackstein ME, Blay JY, Corless C, Driman DK, Riddell R, Soulières D, et al; Canadian Advisory Committee on GIST. Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment. Can J Gastroenterol 2006;20:157-163.
  23. Hwang JH, Rulyak SD, Kimmey MB; American Gastroenterological Association Institute. American Gastroenterological Association Institute technical review on the management of gastric subepithelial masses. Gastroenterology 2006;130:2217-2228. https://doi.org/10.1053/j.gastro.2006.04.033
  24. NCCN guideline for soft tissue sarcoma; 2012 [cited 2013 Feb 1]. Available from: http://www.nccn.org/professionals/ physician_gls/f_guidelines.asp#sarcoma.
  25. Ando N, Goto H, Niwa Y, Hirooka Y, Ohmiya N, Nagasaka T, et al. The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest Endosc 2002;55:37-43. https://doi.org/10.1067/mge.2002.120323
  26. Vander Noot MR 3rd, Eloubeidi MA, Chen VK, Eltoum I, Jhala D, Jhala N, et al. Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer 2004;102:157-163. https://doi.org/10.1002/cncr.20360
  27. Fu K, Eloubeidi MA, Jhala NC, Jhala D, Chhieng DC, Eltoum IE. Diagnosis of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration biopsy--a potential pitfall. Ann Diagn Pathol 2002;6:294-301. https://doi.org/10.1053/adpa.2002.35741
  28. Rodriguez SA, Faigel DO. Endoscopic diagnosis of gastrointestinal stromal cell tumors. Curr Opin Gastroenterol 2007;23:539-543. https://doi.org/10.1097/MOG.0b013e32829fb39f
  29. Wiersema MJ, Wiersema LM, Khusro Q, Cramer HM, Tao LC. Combined endosonography and fine-needle aspiration cytology in the evaluation of gastrointestinal lesions. Gastrointest Endosc 1994;40:199-206. https://doi.org/10.1016/S0016-5107(94)70167-9
  30. Levy MJ, Wiersema MJ. EUS-guided Trucut biopsy. Gastrointest Endosc 2005;62:417-426. https://doi.org/10.1016/j.gie.2005.04.044
  31. Fernandez-Esparrach G, Sendino O, Sole M, Pellise M, Colomo L, Pardo A, et al. Endoscopic ultrasound-guided fineneedle aspiration and trucut biopsy in the diagnosis of gastric stromal tumors: a randomized crossover study. Endoscopy 2010;42:292-299. https://doi.org/10.1055/s-0029-1244074
  32. Ghanem N, Altehoefer C, Furtwangler A, Winterer J, Schafer O, Springer O, et al. Computed tomography in gastrointestinal stromal tumors. Eur Radiol 2003;13:1669-1678. https://doi.org/10.1007/s00330-002-1803-6
  33. Goto O, Kambe H, Niimi K, Mochizuki S, Asada-Hirayama I, Minatsuki C, et al. Discrepancy in diagnosis of gastric submucosal tumor among esophagogastroduodenoscopy, CT, and endoscopic ultrasonography: a retrospective analysis of 93 consecutive cases. Abdom Imaging 2012;37:1074-1078. https://doi.org/10.1007/s00261-012-9928-9
  34. Horton KM, Juluru K, Montogomery E, Fishman EK. Computed tomography imaging of gastrointestinal stromal tumors with pathology correlation. J Comput Assist Tomogr 2004;28:811-817. https://doi.org/10.1097/00004728-200411000-00014
  35. Choi JW, Choi D, Kim KM, Sohn TS, Lee JH, Kim HJ, et al. Small submucosal tumors of the stomach: differentiation of gastric schwannoma from gastrointestinal stromal tumor with CT. Korean J Radiol 2012;13:425-433. https://doi.org/10.3348/kjr.2012.13.4.425
  36. Ulusan S, Koc Z, Kayaselcuk F. Gastrointestinal stromal tumours: CT findings. Br J Radiol 2008;81:618-623. https://doi.org/10.1259/bjr/90134736
  37. Kalkmann J, Zeile M, Antoch G, Berger F, Diederich S, Dinter D, et al; German GIST Imaging Working Group. Consensus report on the radiological management of patients with gastrointestinal stromal tumours (GIST): recommendations of the German GIST Imaging Working Group. Cancer Imaging 2012;12:126-135. https://doi.org/10.1102/1470-7330.2012.0013
  38. Kamiyama Y, Aihara R, Nakabayashi T, Mochiki E, Asao T, Kuwano H, et al. 18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors. World J Surg 2005;29:1429-1435. https://doi.org/10.1007/s00268-005-0045-6
  39. Blay JY, Bonvalot S, Casali P, Choi H, Debiec-Richter M, Dei Tos AP, et al; GIST Consensus Meeting Panelists. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20- 21 March 2004, under the auspices of ESMO. Ann Oncol 2005;16:566-578. https://doi.org/10.1093/annonc/mdi127
  40. Gold JS, Dematteo RP. Combined surgical and molecular therapy: the gastrointestinal stromal tumor model. Ann Surg 2006;244:176-184. https://doi.org/10.1097/01.sla.0000218080.94145.cf
  41. ESMO / European Sarcoma Network Working Group. Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23 Suppl 7:vii49-55. https://doi.org/10.1093/annonc/mds088
  42. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002;33:459-465. https://doi.org/10.1053/hupa.2002.123545
  43. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577-580. https://doi.org/10.1126/science.279.5350.577
  44. Kang GH, Srivastava A, Kim YE, Park HJ, Park CK, Sohn TS, et al. DOG1 and PKC-θ are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors. Mod Pathol 2011;24:866-875. https://doi.org/10.1038/modpathol.2011.11
  45. Liegl B, Hornick JL, Corless CL, Fletcher CD. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Am J Surg Pathol 2009;33:437-446. https://doi.org/10.1097/PAS.0b013e318186b158
  46. Lopes LF, West RB, Bacchi LM, van de Rijn M, Bacchi CE. DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): comparison between 2 different antibodies. Appl Immunohistochem Mol Morphol 2010;18:333-337. https://doi.org/10.1097/PAI.0b013e3181d27ec8
  47. Kim KM, Kang DW, Moon WS, Park JB, Park CK, Sohn JH, et al. PKCtheta expression in gastrointestinal stromal tumor. Mod Pathol 2006;19:1480-1486.
  48. Duensing A, Joseph NE, Medeiros F, Smith F, Hornick JL, Heinrich MC, et al. Protein Kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs). Cancer Res 2004;64:5127-5131. https://doi.org/10.1158/0008-5472.CAN-04-0559
  49. Kang YK, Kang HJ, Kim KM, Sohn T, Choi D, Ryu MH, et al; Korean GIST Study Group (KGSG). Clinical practice guideline for accurate diagnosis and effective treatment of gastrointestinal stromal tumor in Korea. Cancer Res Treat 2012;44:85-96. https://doi.org/10.4143/crt.2012.44.2.85
  50. Blay JY, Le Cesne A, Cassier PA, Ray-Coquard IL. Gastrointestinal stromal tumors (GIST): a rare entity, a tumor model for personalized therapy, and yet ten different molecular subtypes. Discov Med 2012;13:357-367.
  51. Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 2003;21:4342-4349. https://doi.org/10.1200/JCO.2003.04.190
  52. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003;299:708-710. https://doi.org/10.1126/science.1079666
  53. Heinrich MC, Maki RG, Corless CL, Antonescu CR, Harlow A, Griffith D, et al. Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor. J Clin Oncol 2008;26:5352-5359. https://doi.org/10.1200/JCO.2007.15.7461
  54. Corless CL, Schroeder A, Griffith D, Town A, McGreevey L, Harrell P, et al. PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol 2005;23:5357-5364. https://doi.org/10.1200/JCO.2005.14.068
  55. Gronchi A, Blay JY, Trent JC. The role of high-dose imatinib in the management of patients with gastrointestinal stromal tumor. Cancer 2010;116:1847-1858. https://doi.org/10.1002/cncr.24944
  56. Wardelmann E, Hohenberger P, Reichardt P, Merkelbach- Bruse S, Schildhaus HU, Büttner R. Gastrointestinal stromal tumors of the stomach. Updates and differences compared to other locations. Pathologe 2010;31:195-198. https://doi.org/10.1007/s00292-009-1270-9
  57. Pasini B, McWhinney SR, Bei T, Matyakhina L, Stergiopoulos S, Muchow M, et al. Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet 2008;16:79-88. https://doi.org/10.1038/sj.ejhg.5201904
  58. Agaram NP, Wong GC, Guo T, Maki RG, Singer S, Dematteo RP, et al. Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors. Genes Chromosomes Cancer 2008;47:853-859. https://doi.org/10.1002/gcc.20589
  59. Miettinen M, Wang ZF, Sarlomo-Rikala M, Osuch C, Rutkowski P, Lasota J. Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age. Am J Surg Pathol 2011;35:1712-1721. https://doi.org/10.1097/PAS.0b013e3182260752
  60. Lim YJ, Son HJ, Lee JS, Byun YH, Suh HJ, Rhee PL, et al. Clinical course of subepithelial lesions detected on upper gastrointestinal endoscopy. World J Gastroenterol 2010;16:439-444. https://doi.org/10.3748/wjg.v16.i4.439
  61. Gill KR, Camellini L, Conigliaro R, Sassatelli R, Azzolini F, Messerotti A, et al. The natural history of upper gastrointestinal subepithelial tumors: a multicenter endoscopic ultrasound survey. J Clin Gastroenterol 2009;43:723-726. https://doi.org/10.1097/MCG.0b013e31818a8457
  62. Joensuu H, Vehtari A, Riihimaki J, Nishida T, Steigen SE, Brabec P, et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol 2012;13:265-274. https://doi.org/10.1016/S1470-2045(11)70299-6
  63. Rutkowski P, Nowecki ZI, Michej W, Debiec-Rychter M, Wozniak A, Limon J, et al. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor. Ann Surg Oncol 2007;14:2018- 2027. https://doi.org/10.1245/s10434-007-9377-9
  64. Yahchouchy-Chouillard E, Etienne JC, Fagniez PL, Adam R, Fingerhut A. A new "no-touch" technique for the laparoscopic treatment of gastric stromal tumors. Surg Endosc 2002;16:962-964. https://doi.org/10.1007/s00464-001-9041-6
  65. Otani Y, Furukawa T, Yoshida M, Saikawa Y, Wada N, Ueda M, et al. Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases. Surgery 2006;139:484-492. https://doi.org/10.1016/j.surg.2005.08.011
  66. Ryu KJ, Jung SR, Choi JS, Jang YJ, Kim JH, Park SS, et al. Laparoscopic resection of small gastric submucosal tumors. Surg Endosc 2011;25:271-277. https://doi.org/10.1007/s00464-010-1173-0
  67. Nishimura J, Nakajima K, Omori T, Takahashi T, Nishitani A, Ito T, et al. Surgical strategy for gastric gastrointestinal stromal tumors: laparoscopic vs. open resection. Surg Endosc 2007;21:875-878. https://doi.org/10.1007/s00464-006-9065-z
  68. Karakousis GC, Singer S, Zheng J, Gonen M, Coit D, DeMatteo RP, et al. Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a sizematched comparison. Ann Surg Oncol 2011;18:1599-1605. https://doi.org/10.1245/s10434-010-1517-y
  69. De Vogelaere K, Hoorens A, Haentjens P, Delvaux G. Laparoscopic versus open resection of gastrointestinal stromal tumors of the stomach. Surg Endosc 2012. [Epub ahead of print]
  70. Novitsky YW, Kercher KW, Sing RF, Heniford BT. Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg 2006;243:738-745. https://doi.org/10.1097/01.sla.0000219739.11758.27
  71. Sexton JA, Pierce RA, Halpin VJ, Eagon JC, Hawkins WG, Linehan DC, et al. Laparoscopic gastric resection for gastrointestinal stromal tumors. Surg Endosc 2008;22:2583-2587. https://doi.org/10.1007/s00464-008-9807-1
  72. Kim KH, Kim MC, Jung GJ, Kim SJ, Jang JS, Kwon HC. Long term survival results for gastric GIST: is laparoscopic surgery for large gastric GIST feasible? World J Surg Oncol 2012;10:230. https://doi.org/10.1186/1477-7819-10-230
  73. Lee JS, Kim JJ, Park SM. Totally laparoscopic resection for a large gastrointestinal stromal tumor of stomach. J Gastric Cancer 2011;11:239-242. https://doi.org/10.5230/jgc.2011.11.4.239
  74. Sokolich J, Galanopoulos C, Dunn E, Linder JD, Jeyarajah DR. Expanding the indications for laparoscopic gastric resection for gastrointestinal stromal tumors. JSLS 2009;13:165-169.
  75. Thakkar DV, Wani SV, Shetty V, Patankar RV. Laparoscopic sleeve gastrectomy for a large gastrointestinal stromal tumor. Surg Laparosc Endosc Percutan Tech 2012;22:e61-62. https://doi.org/10.1097/SLE.0b013e318244ec34
  76. Henckens T, Van de Putte D, Van Renterghem K, Ceelen W, Pattyn P, Van Nieuwenhove Y. Laparoendoscopic single-site gastrectomy for a gastric GIST using double-bended instruments. J Laparoendosc Adv Surg Tech A 2010;20:469-471. https://doi.org/10.1089/lap.2009.0391
  77. Sasaki A, Koeda K, Nakajima J, Obuchi T, Baba S, Wakabayashi G. Single-incision laparoscopic gastric resection for submucosal tumors: report of three cases. Surg Today 2011;41:133-136. https://doi.org/10.1007/s00595-009-4204-5
  78. Wu SD, Kong J, Su Y, Fan Y. Safety and application of transumbilical single-incision laparoscopic gastrectomy for GIST: SILS in benign gastric disease. Surg Innov 2012. [Epub ahead of print]
  79. Hirano Y, Watanabe T, Uchida T, Yoshida S, Kato H, Hosokawa O. Laparoendoscopic single site partial resection of the stomach for gastrointestinal stromal tumor. Surg Laparosc Endosc Percutan Tech 2010;20:262-264. https://doi.org/10.1097/SLE.0b013e3181e36a5b
  80. Moriyama H, Ishikawa N, Kawaguchi M, Hirose K, Watanabe G. Robot-assisted laparoscopic resection for gastric gastrointestinal stromal tumor. Surg Laparosc Endosc Percutan Tech 2012;22:e155-156. https://doi.org/10.1097/SLE.0b013e3182491ff6
  81. Buchs NC, Bucher P, Pugin F, Hagen ME, Morel P. Robotassisted oncologic resection for large gastric gastrointestinal stromal tumor: a preliminary case series. J Laparoendosc Adv Surg Tech A 2010;20:411-415. https://doi.org/10.1089/lap.2009.0385
  82. Sasaki A, Koeda K, Obuchi T, Nakajima J, Nishizuka S, Terashima M, et al. Tailored laparoscopic resection for suspected gastric gastrointestinal stromal tumors. Surgery 2010;147:516-520. https://doi.org/10.1016/j.surg.2009.10.035
  83. Privette A, McCahill L, Borrazzo E, Single RM, Zubarik R. Laparoscopic approaches to resection of suspected gastric gastrointestinal stromal tumors based on tumor location. Surg Endosc 2008;22:487-494. https://doi.org/10.1007/s00464-007-9493-4
  84. Kakeji Y, Nakanoko T, Yoshida R, Eto K, Kumashiro R, Ikeda K, et al. Laparoscopic resection for gastrointestinal stromal tumors in the stomach. Surg Today 2012;42:554-558. https://doi.org/10.1007/s00595-011-0072-x
  85. Hyung WJ, Lim JS, Cheong JH, Kim J, Choi SH, Noh SH. Laparoscopic resection of a huge intraluminal gastric submucosal tumor located in the anterior wall: eversion method. J Surg Oncol 2005;89:95-98. https://doi.org/10.1002/jso.20195
  86. Hepworth CC, Menzies D, Motson RW. Minimally invasive surgery for posterior gastric stromal tumors. Surg Endosc 2000;14:349-353. https://doi.org/10.1007/s004640020062
  87. Ibrahim IM, Silvestri F, Zingler B. Laparoscopic resection of posterior gastric leiomyoma. Surg Endosc 1997;11:277-279. https://doi.org/10.1007/s004649900343
  88. Hwang SH, Park do J, Kim YH, Lee KH, Lee HS, Kim HH, et al. Laparoscopic surgery for submucosal tumors located at the esophagogastric junction and the prepylorus. Surg Endosc 2009;23:1980-1987. https://doi.org/10.1007/s00464-008-9955-3
  89. Wilhelm D, von Delius S, Burian M, Schneider A, Frimberger E, Meining A, et al. Simultaneous use of laparoscopy and endoscopy for minimally invasive resection of gastric subepithelial masses - analysis of 93 interventions. World J Surg 2008;32:1021-1028. https://doi.org/10.1007/s00268-008-9492-1
  90. Wong DC, Wong SK, Leung AL, Chung CC, Li MK. Combined endolaparoscopic intragastric excision for gastric neoplasms. J Laparoendosc Adv Surg Tech A 2009;19:765-770. https://doi.org/10.1089/lap.2009.0067
  91. Sakamoto Y, Sakaguchi Y, Akimoto H, Chinen Y, Kojo M, Sugiyama M, et al. Safe laparoscopic resection of a gastric gastrointestinal stromal tumor close to the esophagogastric junction. Surg Today 2012;42:708-711. https://doi.org/10.1007/s00595-012-0121-0
  92. Song KY, Kim SN, Park CH. Tailored-approach of laparoscopic wedge resection for treatment of submucosal tumor near the esophagogastric junction. Surg Endosc 2007;21: 2272-2276. https://doi.org/10.1007/s00464-007-9369-7
  93. Ma JJ, Hu WG, Zang L, Yan XW, Lu AG, Wang ML, et al. Laparoscopic gastric resection approaches for gastrointestinal stromal tumors of stomach. Surg Laparosc Endosc Percutan Tech 2011;21:101-105. https://doi.org/10.1097/SLE.0b013e3182139546
  94. Warsi AA, Peyser PM. Laparoscopic resection of gastric GIST and benign gastric tumours: evolution of a new technique. Surg Endosc 2010;24:72-78. https://doi.org/10.1007/s00464-009-0561-9
  95. Ludwig K, Wilhelm L, Scharlau U, Amtsberg G, Bernhardt J. Laparoscopic-endoscopic rendezvous resection of gastric tumors. Surg Endosc 2002;16:1561-1565. https://doi.org/10.1007/s00464-001-9224-1
  96. Tagaya N, Mikami H, Kogure H, Kubota K, Hosoya Y, Nagai H. Laparoscopic intragastric stapled resection of gastric submucosal tumors located near the esophagogastric junction. Surg Endosc 2002;16:177-179. https://doi.org/10.1007/s004640080158
  97. Sahm M, Pross M, Lippert H. Intraluminal resection of gastric tumors using intragastric trocar technique. Surg Laparosc Endosc Percutan Tech 2011;21:e169-172. https://doi.org/10.1097/SLE.0b013e318221749c
  98. Walsh RM, Ponsky J, Brody F, Matthews BD, Heniford BT. Combined endoscopic/laparoscopic intragastric resection of gastric stromal tumors. J Gastrointest Surg 2003;7:386-392. https://doi.org/10.1016/S1091-255X(02)00436-5
  99. Sekimoto M, Tamura S, Hasuike Y, Yano M, Murata A, Inoue M, et al. A new technique for laparoscopic resection of a submucosal tumor on the posterior wall of the gastric fundus. Surg Endosc 1999;13:71-74. https://doi.org/10.1007/s004649900902
  100. Shim JH, Lee HH, Yoo HM, Jeon HM, Park CH, Kim JG, et al. Intragastric approach for submucosal tumors located near the Z-line: a hybrid laparoscopic and endoscopic technique. J Surg Oncol 2011;104:312-315. https://doi.org/10.1002/jso.21934
  101. Uchikoshi F, Ito T, Nishida T, Kitagawa T, Endo S, Matsuda H. Laparoscopic intragastric resection of gastric stromal tumor located at the esophago-cardiac junction. Surg Laparosc Endosc Percutan Tech 2004;14:1-4.
  102. Rosen MJ, Heniford BT. Endoluminal gastric surgery: the modern era of minimally invasive surgery. Surg Clin North Am 2005;85:989-1007, vii. https://doi.org/10.1016/j.suc.2005.05.010
  103. Li VK, Hung WK, Chung CK, Ying MW, Lam BY, Kan DM, et al. Laparoscopic intragastric approach for stromal tumours located at the posterior gastric wall. Asian J Surg 2008;31:6-10. https://doi.org/10.1016/S1015-9584(08)60047-0
  104. Tagaya N, Mikami H, Kubota K. Laparoscopic resection of gastrointestinal mesenchymal tumors located in the upper stomach. Surg Endosc 2004;18:1469-1474. https://doi.org/10.1007/s00464-004-8800-6
  105. Hiki N, Yamamoto Y, Fukunaga T, Yamaguchi T, Nunobe S, Tokunaga M, et al. Laparoscopic and endoscopic cooperative surgery for gastrointestinal stromal tumor dissection. Surg Endosc 2008;22:1729-1735. https://doi.org/10.1007/s00464-007-9696-8
  106. Abe N, Takeuchi H, Yanagida O, Masaki T, Mori T, Sugiyama M, et al. Endoscopic full-thickness resection with laparoscopic assistance as hybrid NOTES for gastric submucosal tumor. Surg Endosc 2009;23:1908-1913. https://doi.org/10.1007/s00464-008-0317-y
  107. Tsujimoto H, Yaguchi Y, Kumano I, Takahata R, Ono S, Hase K. Successful gastric submucosal tumor resection using laparoscopic and endoscopic cooperative surgery. World J Surg 2012;36:327-330. https://doi.org/10.1007/s00268-011-1387-x
  108. Palmes D, Weilinghoff M, Colombo-Benkmann M, Senninger N, Bruewer M. Effect of pyloric drainage procedures on gastric passage and bile reflux after esophagectomy with gastric conduit reconstruction. Langenbecks Arch Surg 2007;392:135-141. https://doi.org/10.1007/s00423-006-0119-4
  109. Lee JS, Kim JJ, Park SM. Laparoscopic gastric wedge resection and prophylactic antireflux surgery for a submucosal tumor of gastroesophageal junction. J Gastric Cancer 2011;11:131-134. https://doi.org/10.5230/jgc.2011.11.2.131
  110. Huang ZG, Zhang XS, Huang SL, Yuan XG. Endoscopy dissection of small stromal tumors emerged from the muscularis propria in the upper gastrointestinal tract: Preliminary study. World J Gastrointest Endosc 2012;4:565-570. https://doi.org/10.4253/wjge.v4.i12.565
  111. Huang LY, Cui J, Liu YX, Wu CR, Yi DL. Endoscopic therapy for gastric stromal tumors originating from the muscularis propria. World J Gastroenterol 2012;18:3465-3471. https://doi.org/10.3748/wjg.v18.i26.3465
  112. Jeong ID, Jung SW, Bang SJ, Shin JW, Park NH, Kim do H. Endoscopic enucleation for gastric subepithelial tumors originating in the muscularis propria layer. Surg Endosc 2011;25:468-474. https://doi.org/10.1007/s00464-010-1195-7
  113. Lee IL, Lin PY, Tung SY, Shen CH, Wei KL, Wu CS. Endoscopic submucosal dissection for the treatment of intraluminal gastric subepithelial tumors originating from the muscularis propria layer. Endoscopy 2006;38:1024-1028. https://doi.org/10.1055/s-2006-944814
  114. Bialek A, Wiechowska-Kozlowska A, Pertkiewicz J, Polkowski M, Milkiewicz P, Karpinska K, et al. Endoscopic submucosal dissection for treatment of gastric subepithelial tumors (with video). Gastrointest Endosc 2012;75:276-286. https://doi.org/10.1016/j.gie.2011.08.029
  115. Li QL, Yao LQ, Zhou PH, Xu MD, Chen SY, Zhong YS, et al. Submucosal tumors of the esophagogastric junction originating from the muscularis propria layer: a large study of endoscopic submucosal dissection (with video). Gastrointest Endosc 2012;75:1153-1158. https://doi.org/10.1016/j.gie.2012.01.037
  116. Bai J, Wang Y, Guo H, Zhang P, Ling X, Zhao X. Endoscopic resection of small gastrointestinal stromal tumors. Dig Dis Sci 2010;55:1950-1954. https://doi.org/10.1007/s10620-010-1168-7
  117. Catalano F, Rodella L, Lombardo F, Silano M, Tomezzoli A, Fuini A, et al. Endoscopic submucosal dissection in the treatment of gastric submucosal tumors: results from a retrospective cohort study. Gastric Cancer 2012. [Epub ahead of print]
  118. Kakushima N, Yahagi N, Fujishiro M, Kodashima S, Nakamura M, Omata M. Efficacy and safety of endoscopic submucosal dissection for tumors of the esophagogastric junction. Endoscopy 2006;38:170-174. https://doi.org/10.1055/s-2005-921039
  119. Waterman AL, Grobmyer SR, Cance WG, Hochwald SN. Is endoscopic resection of gastric gastrointestinal stromal tumors safe? Am Surg 2008;74:1186-1189.
  120. Wang L, Ren W, Fan CQ, Li YH, Zhang X, Yu J, et al. Fullthickness endoscopic resection of nonintracavitary gastric stromal tumors: a novel approach. Surg Endosc 2011;25:641-647. https://doi.org/10.1007/s00464-010-1189-5
  121. Zhou PH, Yao LQ, Qin XY, Cai MY, Xu MD, Zhong YS, et al. Endoscopic full-thickness resection without laparoscopic assistance for gastric submucosal tumors originated from the muscularis propria. Surg Endosc 2011;25:2926-2931. https://doi.org/10.1007/s00464-011-1644-y
  122. Gold JS, Gonen M, Gutierrez A, Broto JM, Garcia-del-Muro X, Smyrk TC, et al. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol 2009;10:1045- 1052. https://doi.org/10.1016/S1470-2045(09)70242-6
  123. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, et al. AJCC Cancer Staging Handbook; from the AJCC Cancer Staging Manual. 7th ed. New York: Springer-Verlag, 2010:170-180.
  124. Dematteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, et al; American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet 2009;373:1097- 1104. https://doi.org/10.1016/S0140-6736(09)60500-6
  125. Joensuu H, Eriksson M, Sundby Hall K, Hartmann JT, Pink D, Schütte J, et al. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA 2012;307:1265-1272. https://doi.org/10.1001/jama.2012.347
  126. Joensuu H, Trent JC, Reichardt P. Practical management of tyrosine kinase inhibitor-associated side effects in GIST. Cancer Treat Rev 2011;37:75-88. https://doi.org/10.1016/j.ctrv.2010.04.008
  127. Reichardt P, Blay JY, Boukovinas I, Brodowicz T, Broto JM, Casali PG, et al. Adjuvant therapy in primary GIST: state-ofthe- art. Ann Oncol 2012;23:2776-2781. https://doi.org/10.1093/annonc/mds198
  128. Gouveia AM, Pimenta AP, Capelinha AF, de la Cruz D, Silva P, Lopes JM. Surgical margin status and prognosis of gastrointestinal stromal tumor. World J Surg 2008;32:2375-2382. https://doi.org/10.1007/s00268-008-9704-8
  129. McCarter MD, Antonescu CR, Ballman KV, Maki RG, Pisters PW, Demetri GD, et al; American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant Gist Study Team. Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence. J Am Coll Surg 2012;215:53-59. https://doi.org/10.1016/j.jamcollsurg.2012.05.008
  130. Hohenberger P, Ronellenfitsch U, Oladeji O, Pink D, Ströbel P, Wardelmann E, et al. Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour. Br J Surg 2010;97:1854-1859. https://doi.org/10.1002/bjs.7222
  131. Goh BK, Chow PK, Chuah KL, Yap WM, Wong WK. Patho logic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate. Eur J Surg Oncol 2006;32:961-963. https://doi.org/10.1016/j.ejso.2006.06.004
  132. Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, et al. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol 2007;14:14-24.
  133. Hohenberger P, Eisenberg B. Role of surgery combined with kinase inhibition in the management of gastrointestinal stromal tumor (GIST). Ann Surg Oncol 2010;17:2585-2600. https://doi.org/10.1245/s10434-010-1053-9
  134. Doyon C, Sideris L, Leblanc G, Leclerc YE, Boudreau D, Dube P. Prolonged therapy with imatinib mesylate before surgery for advanced gastrointestinal stromal tumor results of a phase II trial. Int J Surg Oncol 2012;2012:761576.
  135. Verweij J, Casali PG, Zalcberg J, LeCesne A, Reichardt P, Blay JY, et al. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet 2004;364:1127-1134. https://doi.org/10.1016/S0140-6736(04)17098-0
  136. Haller F, Detken S, Schulten HJ, Happel N, Gunawan B, Kuhlgatz J, et al. Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations. Ann Surg Oncol 2007;14:526-532. https://doi.org/10.1245/s10434-006-9228-0
  137. Blesius A, Cassier PA, Bertucci F, Fayette J, Ray-Coquard I, Bui B, et al. Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial. BMC Cancer 2011;11:72. https://doi.org/10.1186/1471-2407-11-72
  138. Wang D, Zhang Q, Blanke CD, Demetri GD, Heinrich MC, Watson JC, et al. Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132. Ann Surg Oncol 2012;19:1074-1080. https://doi.org/10.1245/s10434-011-2190-5
  139. Choi H. Response evaluation of gastrointestinal stromal tumors. Oncologist 2008;13 Suppl 2:4-7.
  140. Van den Abbeele AD. The lessons of GIST--PET and PET/CT: a new paradigm for imaging. Oncologist 2008;13 Suppl 2:8-13. https://doi.org/10.1634/theoncologist.13-S2-8
  141. UMIN-CTR, id number UMIN000003114. Available from: https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=b rows&action=brows&type=summary&recptno=R000003763 &language=E.
  142. Clinicaltrials.gov id NCT00112632. Available from: http:// www.clinicaltrials.gov/ct2/show/NCT00112632?term=neoadj uvant+gist&rank=3.
  143. Eisenberg BL, Harris J, Blanke CD, Demetri GD, Heinrich MC, Watson JC, et al. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/ recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. J Surg Oncol 2009;99: 42-47. https://doi.org/10.1002/jso.21160

피인용 문헌

  1. Rolle und Aufgaben der chirurgischen Onkologie im Rahmen molekular definierter Therapien vol.19, pp.10, 2013, https://doi.org/10.1007/s00761-013-2499-8
  2. Diagnosis and Treatment of Gastrointestinal Stromal Tumor vol.85, pp.4, 2013, https://doi.org/10.3904/kjm.2013.85.4.341
  3. Laparoscopic surgery for double gastrointestinal stromal tumor of the stomach: a report of two cases vol.12, pp.None, 2013, https://doi.org/10.1186/1477-7819-12-76
  4. Minimally invasive surgery for submucosal (subepithelial) tumors of the stomach vol.20, pp.36, 2014, https://doi.org/10.3748/wjg.v20.i36.13035
  5. Gastrointestinal Stromal Tumors in the 21&lt;sup&gt;st&lt;/sup&gt; Century vol.5, pp.8, 2014, https://doi.org/10.4236/jct.2014.58086
  6. Higher incidence of gastroesophageal reflux disease after gastric wedge resections of gastric submucosal tumors located close to the gastroesophageal junction vol.86, pp.6, 2014, https://doi.org/10.4174/astr.2014.86.6.289
  7. Laparoscopic versus open gastric resection for larger than 5 cm primary gastric gastrointestinal stromal tumors (GIST): a size-matched comparison vol.28, pp.9, 2013, https://doi.org/10.1007/s00464-014-3506-x
  8. Giant gastrointestinal stromal tumour of rare sarcomatoid epithelioid subtype: Case study and literature review vol.21, pp.11, 2015, https://doi.org/10.3748/wjg.v21.i11.3388
  9. Cap‐aspiration lumpectomy for small submucosal tumors originating from the muscularis propria of the gastric fundus: a preliminary study (with videos) vol.16, pp.11, 2013, https://doi.org/10.1111/1751-2980.12292
  10. Novel method for hybrid endo-laparoscopic full-thickness gastric resection using laparoscopic transgastric suture passer device vol.30, pp.4, 2013, https://doi.org/10.1007/s00464-015-4375-7
  11. Comparison of minilaparoscopy and single-incision intragastric surgery for gastric submucosal tumor resection in a porcine model vol.30, pp.10, 2016, https://doi.org/10.1007/s00464-016-4781-5
  12. Small EUS-suspected gastrointestinal stromal tumors of the stomach: An overview for the current state of management vol.5, pp.2, 2016, https://doi.org/10.4103/2303-9027.180469
  13. Laparoscopic, Trans-Gastric Endoscopic Removal of Gastroesophageal Junction Gastrointestinal Stromal Tumors (GIST) vol.83, pp.7, 2017, https://doi.org/10.1177/000313481708300708
  14. Laparoscopic resection for gastrointestinal stromal tumors in esophagogastric junction (EGJ): how to protect the EGJ vol.32, pp.2, 2013, https://doi.org/10.1007/s00464-017-5776-6
  15. Effectiveness and safety of endoscopic resection for gastric GISTs: a systematic review vol.27, pp.3, 2013, https://doi.org/10.1080/13645706.2017.1347097
  16. Importance of Early Diagnosis of Gastrointestinal Stromal Tumors of the Stomach: Our 5-Year, Single-Center Experience vol.102, pp.9, 2013, https://doi.org/10.9738/intsurg-d-17-00076.1
  17. Gastrointestinal stromal tumours of stomach: Robot-assisted excision with the da Vinci Surgical System regardless of size and location site vol.15, pp.2, 2013, https://doi.org/10.4103/jmas.jmas_260_17
  18. Multifocal gastrointestinal stromal tumor: A case report with CT, surgical, and histopathologic correlation vol.14, pp.8, 2019, https://doi.org/10.1016/j.radcr.2019.05.015
  19. Surgical Outcomes of Single-Port and Multiport Laparoscopic Resection for Gastric Gastrointestinal Stromal Tumors (GIST): a Single-Center Experience vol.81, pp.3, 2013, https://doi.org/10.1007/s12262-018-1781-9
  20. Safety profile and oncological outcomes of gastric gastrointestinal stromal tumors (GISTs) robotic resection: Single center experience vol.15, pp.6, 2019, https://doi.org/10.1002/rcs.2031
  21. Magnetically Actuated Soft Capsule Endoscope for Fine-Needle Biopsy vol.7, pp.1, 2013, https://doi.org/10.1089/soro.2018.0171
  22. Robotic surgery for gastric gastrointestinal stromal tumors: A single center case series vol.122, pp.4, 2020, https://doi.org/10.1002/jso.26053
  23. Resection of the gastric submucosal tumor (G-SMT) originating from the muscularis propria layer: comparison of efficacy, patients’ tolerability, and clinical outcomes between endoscopic full-thi vol.34, pp.9, 2013, https://doi.org/10.1007/s00464-019-07311-x
  24. Feasibility of Non-Exposure Simple Suturing Endoscopic Full-Thickness Resection in Comparison with Laparoscopic Endoscopic Cooperative Surgery for Gastric Subepithelial Tumors: Results of Two Independ vol.13, pp.8, 2013, https://doi.org/10.3390/cancers13081858